Fungating Metastatic Breast Cancer, a Challenging Case Report of Bleeding Control and Palliative Wound Care
Haynes Addison,
Simman Richard
Issue:
Volume 2, Issue 3, May 2014
Pages:
29-32
Received:
7 May 2014
Accepted:
29 May 2014
Published:
10 June 2014
Abstract: This case will discuss the palliative care in an advanced metastatic and fungating breast cancer. As sometimes happens, patients elect to go with different means of treatment and not the mastectomy with lymph node dissection, radiation, and chemotherapy that is the standard of care. Even though the patient elected not to attempt the full surgery, there are still surgical options that could have helped her quality of life and are important to consider. Wound care can be curative for many different wounds but can also greatly improve the quality of life that is present. Wounds leave the body exposed to secondary infections and can produce foul odor which is not conducive to patient or family comfort and happiness. It can be used in conjunction with many different treatments and should not be forgotten in the treatment of all patients. In this case we also discussed a variety of methods for bleeding control of this cancerous mass.
Abstract: This case will discuss the palliative care in an advanced metastatic and fungating breast cancer. As sometimes happens, patients elect to go with different means of treatment and not the mastectomy with lymph node dissection, radiation, and chemotherapy that is the standard of care. Even though the patient elected not to attempt the full surgery, t...
Show More
Regression of Carotid Plaques in Individuals at Low-to-intermediate Cardiovascular Risk Treated with Citozym and Propulzym
Torricelli Piera,
Ferorelli Pasquale,
De Martino Angelo,
Antonelli Francesco,
Shevchenko Anna,
Beninati Simone
Issue:
Volume 2, Issue 3, May 2014
Pages:
33-37
Received:
29 May 2014
Accepted:
17 June 2014
Published:
20 July 2014
Abstract: A prospective trial was performed to assess coronary plaque regression following about 5 months of treatments with two dietary supplements, Citozym and Propulzym. Coronary segments that included the most diseased plaque of 20 selected patients were analyzed using carotid ultrasound (CDUS). Inclusion criteria were as follows: 20 subjects (10 of control group and 10 of test group) aged between 54 and 74 years with a clear diagnosis of carotid plaque and stenosis percentage of not less than 40% and not more than 70%. The data obtained showed a wide inter-individual variability, with a range of reduction from 4% to 27%. It is interesting to note that the plaque reduction in one patient reached a value of about 27% observable with the ultrasonic examination. Since it is clear that carotid plaque morphology/stability is one of the most important factor regarding the definition of cardiovascular risk, our preliminary results suggest the possibility of a non-invasive treatment of carotid plaque.
Abstract: A prospective trial was performed to assess coronary plaque regression following about 5 months of treatments with two dietary supplements, Citozym and Propulzym. Coronary segments that included the most diseased plaque of 20 selected patients were analyzed using carotid ultrasound (CDUS). Inclusion criteria were as follows: 20 subjects (10 of cont...
Show More
